Stocks
Editas Medicine (EDIT) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -687.1% | -148.6% | -756.1% | -1 146% | -208.8% | -357.4% | ||
| Changes by years, y/y, % | -332pp | +538pp | -608pp | -390pp | +937pp | -10.1% | |||
Editas Medicine. EBITDA margin, %
Editas Medicine. EBITDA margin, changes, pp
Editas Medicine (EDIT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -843.7% | -37.5% | -5 778% | -13 739% | -101 870% | -357.4% | |
| Changes by years, y/y, % | +132 290pp | +933pp | -5 261pp | -12 212pp | -101 027pp | |||
| Changes by quarters, q/q, % | +684pp | +806pp | -5 741pp | -7 961pp | -88 131pp | |||
